DFTX
Definium Therapeutics, Inc.
NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY
$21.40
-2.95% today
Updated 2026-05-11
Market cap
$2.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.50
Dividend yield
—
52W range
$6 – $26
Volume
1.9M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$39.53
+84.72%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-42.63M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net income | $-56.80M | $-95.73M | $-108.68M | $-183.79M | $-77.10M |
| EPS | — | — | — | — | $-2.50 |
| Free cash flow | $-50.14M | $-64.36M | $-79.13M | $-131.56M | $-42.63M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Definium Therapeutics, Inc. trades at $21.40. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Definium Therapeutics, Inc.'s stock price?
Definium Therapeutics, Inc. (DFTX) trades at $21.40.
Is Definium Therapeutics, Inc. overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Definium Therapeutics, Inc. (DFTX)?
The analyst target price is $39.53, representing +84.7% upside from the current price of $21.40.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-64.10%
Beta2.38
50D MA$20.18
200D MA$14.43
Shares out0.11B
Float0.10B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—